Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue

被引:123
作者
Jeong, Hii Sun [1 ]
Lee, Byeong Ho [1 ]
Sung, Ha Min [1 ]
Park, Sook Young [1 ]
Ahn, Duk Kyun [1 ]
Jung, Min Su [1 ]
Suh, In Suck [1 ]
机构
[1] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Plast & Reconstruct Surg, Seoul 150950, South Korea
关键词
HYPERTROPHIC SCARS; GRANULATION-TISSUE; FACIAL WOUNDS; MYOFIBROBLASTS; REPAIR;
D O I
10.1097/PRS.0000000000001438
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background: Although botulinum toxin type A has been shown to inhibit the formation of hypertrophic scars, little is known about the underlying mechanisms of action. Studies have reported that botulinum toxin type A is able to inhibit fibroblast proliferation and transforming growth factor (TGF)-beta 1 expression; therefore, in this study, the authors evaluated its effect on the differentiation of fibroblasts derived from normal and hypertrophic scar tissue. Methods: Under local anesthesia, tissue specimens from 10 scars (five normal mature scars and five hypertrophic scars) were obtained from nine patients who visited the authors' department for scar revision. Fibroblasts isolated from the tissue specimens were cultured until confluent and pretreated with TGF-beta 1 to induce differentiation before treatment with botulinum toxin type A. Expression of the myofibroblast marker alpha-smooth muscle actin in cell cultures was evaluated by enzyme-linked immunosorbent assay and quantitative reverse transcription polymerase chain reaction. Fibroblast-to-myofibroblast differentiation was further evaluated by immunocytochemistry and confocal microscopy. Results: The authors' results showed that alpha-smooth muscle actin mRNA and protein levels were significantly lower in the botulinum toxin type A-treated group than in the control group (treated with TGF-beta 1 only) of fibroblasts derived from hypertrophic scars, but not fibroblasts derived from normal scars. Immunocytochemistry results also showed that fibroblast-to-myofibroblast differentiation was significantly decreased after botulinum toxin type A treatment in fibroblasts derived from hypertrophic scars. Conclusion: The authors' results show that botulinum toxin type A directly inhibits fibroblast-to-myofibroblast differentiation in vitro, and indicate its potential for use in treating wounds expected to develop into hypertrophic scars after trauma, burn, or surgery.
引用
收藏
页码:171E / 178E
页数:8
相关论文
共 21 条
[1]
Botulinum Toxin to Improve Results in Cleft Lip Repair [J].
Chang, Chun-Shin ;
Wallace, Christopher Glenn ;
Hsiao, Yen-Chang ;
Chang, Chee-Jen ;
Chen, Philip Kuo-Ting .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 134 (03) :511-516
[2]
TRANSFORMING GROWTH-FACTOR-BETA-1 INDUCES ALPHA-SMOOTH MUSCLE ACTIN EXPRESSION IN GRANULATION-TISSUE MYOFIBROBLASTS AND IN QUIESCENT AND GROWING CULTURED FIBROBLASTS [J].
DESMOULIERE, A ;
GEINOZ, A ;
GABBIANI, F ;
GABBIANI, G .
JOURNAL OF CELL BIOLOGY, 1993, 122 (01) :103-111
[3]
Modeling dermal granulation tissue with the linear fibroblast-populated collagen matrix: A comparison with the round matrix model [J].
Eichler, MJ ;
Carlson, MA .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2006, 41 (02) :97-108
[4]
Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates [J].
Gassner, HG ;
Sherris, DA ;
Otley, CC ;
Larrabee, WF .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 105 (06) :1954-1955
[5]
Chemoimmobilization: Improving predictability in the treatment of facial scars [J].
Gassner, HG ;
Sherris, DA .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 112 (05) :1464-1466
[6]
AESTHETIC INDICATIONS FOR BOTULINUM TOXIN INJECTION [J].
GUYURON, B ;
HUDDLESTON, SW .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1994, 93 (05) :913-918
[7]
The myofibroblast: Paradigm for a mechanically active cell [J].
Hinz, Boris .
JOURNAL OF BIOMECHANICS, 2010, 43 (01) :146-155
[8]
Botulinum Toxin to Minimize Facial Scarring [J].
Jablonka, Eric M. ;
Sherris, David A. ;
Gassner, Holger G. .
FACIAL PLASTIC SURGERY, 2012, 28 (05) :525-535
[9]
The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids [J].
Ogawa, Rei .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2010, 125 (02) :557-568
[10]
Keloid scars and treatment with Botulinum Toxin Type A: The Belfast experience [J].
Robinson, Andrew J. ;
Khadim, Muhammad F. ;
Khan, Khalid .
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2013, 66 (03) :439-440